Irem Namli, Ph.D., is a Postdoctoral Research Fellow at Tampere University, where she develops nano-in-micro inhalable formulations for tuberculosis treatment. She also conducts postdoctoral research at the University of Helsinki, focusing on nanosystems, microsystems, cocrystals and nanocrystal formulations using Design of Experiments and advanced pharmaceutical processing techniques.
She holds a Ph.D. in Pharmaceutical Technology and a Bachelor of Pharmacy from Anadolu University, Türkiye. Her doctoral research investigated extended-release acyclovir nanofibers developed through a Quality by Design approach and evaluated through in vitro and in vivo studies. She previously worked as a visiting researcher at the University of Helsinki.
Her main research interests include advanced drug-delivery systems, nanopharmaceutical formulations, inhalable medicines, polymeric and lipid nanoparticles, electrospun nanofibers, hot-melt extrusion and formulation optimisation. Her technical expertise spans pharmaceutical characterisation, dissolution method development, permeability studies, chromatographic and spectroscopic analysis, and animal experimentation.
Dr. Namli’s work integrates formulation science, nanotechnology and translational pharmaceutical research to support the development of innovative therapeutic systems.
